HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Chronic liver disease after treatment of malignancies in children].

Abstract
Chemotherapy, which has greatly improved the prognosis of children with malignant diseases, is potentially hepatotoxic. Furthermore, there is a risk for viral hepatitis acquired by blood products. In this study we looked for hepatotoxicity and for chronic viral hepatitis during and after chemotherapy in 50 unselected children with malignant diseases. 29 children had been treated for leukemia or lymphoma, 19 for solid tumors, 2 for histiocytosis. All patients had been treated before 1991 and had received blood products not screened for hepatitis C-antibodies. In 18 girls and 32 boys aged 12.3 years (range 6.7-24.5 years) hepatitis B- and hepatitis C-serology and liver function tests were measured during a routine check-up 3.6 years (range 0.5-11.8 years) after the last chemotherapy. Liver function tests during chemotherapy were reviewed retrospectively. During chemotherapy 86% of children showed increased ALT and AST levels, 10% had levels above 500 U/l. At follow up 16 children (32%) had pathological liver function tests, especially slightly increased AST and ALT, 13 of these 16 patients had chronic hepatitis C. In contrast only 2 of 34 patients with normal liver function tests had a viral hepatitis (p = 0.001). Patients with elevation of AST and ALT above 100 U/l during chemotherapy had significantly more often a viral hepatitis than those with normal or slightly elevated aminotransferases. Our study shows that hepatocellular damage is a frequent complication following chemotherapy. However this progresses to chronic liver disease very rarely unless the patient acquired a viral hepatitis. The prevalence of chronic hepatitis C was very high in our patients. As screening of blood products for hepatitis C-antibodies is routinely performed since 1991 this problem is likely to have decreased.
AuthorsA Ballauff, J Krähe, B Jansen, R S Ross, H Roggendorf, W Havers
JournalKlinische Padiatrie (Klin Padiatr) 1999 Mar-Apr Vol. 211 Issue 2 Pg. 49-52 ISSN: 0300-8630 [Print] Germany
Vernacular TitleChronische Hepatopathien nach Behandlung maligner Erkrankungen bei Kindern.
PMID10407809 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Aspartate Aminotransferases
  • Alanine Transaminase
Topics
  • Adolescent
  • Adult
  • Alanine Transaminase (analysis)
  • Antineoplastic Agents (adverse effects)
  • Aspartate Aminotransferases (analysis)
  • Blood Banks (legislation & jurisprudence)
  • Child
  • Chronic Disease
  • Female
  • Follow-Up Studies
  • Germany (epidemiology)
  • Hepatitis C, Chronic (diagnosis, epidemiology, etiology)
  • Humans
  • Incidence
  • Liver Diseases (diagnosis, epidemiology, etiology)
  • Liver Function Tests
  • Male
  • Neoplasms (therapy)
  • Transfusion Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: